SCHEMBL14417878

SCHEMBL14417878

Cc1c(S(=O)(=O)NC(c2ccccc2)c2ccccc2)oc2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.67
▸ ALDH1A1 P00352 5/20 0.67
▸ KMT2A Q03164 5/20 0.67
▸ CES2 O00748 4/20 0.67
▸ HPGD P15428 4/20 0.67
▸ HSD17B10 Q99714 4/20 0.67
▸ CYP3A4 P08684 3/20 0.67
▸ BLM P54132 3/20 0.67
▸ ALOX15 P16050 2/20 0.67
▸ BRCA1 P38398 2/20 0.67
▸ IDO1 P14902 3/20 0.56
▸ HIF1A Q16665 4/20 0.52
▸ EPAS1 Q99814 4/20 0.52
▸ KDM4E B2RXH2 3/20 0.52
▸ MAPT P10636 3/20 0.52
▸ RECQL P46063 3/20 0.52
▸ TDP1 Q9NUW8 3/20 0.52
▸ POLB P06746 2/20 0.52
▸ CES1 P23141 2/20 0.52
▸ PTPN6 P29350 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14417876 0.93 MEN1 (0.59) MEN1ALDH1A1KMT2ACES2HPGD
SCHEMBL14417882 0.82 MEN1 (0.65) MEN1ALDH1A1KMT2ACES2HPGD
SCHEMBL14417881 0.80 MEN1 (0.80) MEN1ALDH1A1KMT2ACES2HPGD
Tanshinone Iia Sulfonic Acid SCHEMBL14417738 0.80 MEN1 (0.80) MEN1ALDH1A1KMT2ACES2HPGD
Tanshinone Iia Sulfonic Acid SCHEMBL30094475 0.80 MEN1 (1.00) MEN1ALDH1A1KMT2ACES2HPGD
Tanshinone Iia Sulfonic Acid SCHEMBL28665868 0.80 MEN1 (1.00) MEN1ALDH1A1KMT2ACES2HPGD
SCHEMBL14417875 0.78 MEN1 (0.66) MEN1ALDH1A1KMT2ACES2HPGD
SCHEMBL14417745 0.74 IDO1 (0.55) MEN1ALDH1A1KMT2ACES2HPGD
SCHEMBL14417705 0.74 IDO1 (0.62) MEN1ALDH1A1KMT2ACES2HPGD
SCHEMBL14417741 0.72 MEN1 (0.67) MEN1ALDH1A1KMT2ACES2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070207989-A1 DITERPENE DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR, CANCER AND INFLAMMATORY DISEASES SAVIPU PHARMACEUTICALS (US) 2007-09-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070207989-A1 DITERPENE DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR, CANCER AND INFLAMMATORY DISEASES NFKBIA, EDNRA, EDNRB MEN1 3639/4885ALDH1A1 2108/4885KMT2A 4424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback